Prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic test
Deanna G. Brockman, View ORCID ProfileChristina A. Austin-Tse, Renée C. Pelletier, Caroline Harley, Candace Patterson, Holly Head, Courtney Elizabeth Leonard, Kimberly O’Brien, Lisa M. Mahanta, Matthew S. Lebo, Christine Y. Lu, View ORCID ProfilePradeep Natarajan, Amit V. Khera, Krishna G. Aragam, Sekar Kathiresan, Heidi L. Rehm, Miriam Udler
doi: https://doi.org/10.1101/2020.09.03.20181073
Deanna G. Brockman
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
2Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
M.S., C.G.CChristina A. Austin-Tse
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
3Laboratory for Molecular Medicine, Partners Personalized Medicine, Cambridge, Massachusetts
5Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts
Ph.D., FACMGRenée C. Pelletier
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
2Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
M.S., C.G.CCaroline Harley
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
B.S.Candace Patterson
2Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
B.S.Holly Head
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
M.S., C.G.CCourtney Elizabeth Leonard
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
2Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
B.S.Kimberly O’Brien
3Laboratory for Molecular Medicine, Partners Personalized Medicine, Cambridge, Massachusetts
B.S.Lisa M. Mahanta
3Laboratory for Molecular Medicine, Partners Personalized Medicine, Cambridge, Massachusetts
B.S.Matthew S. Lebo
3Laboratory for Molecular Medicine, Partners Personalized Medicine, Cambridge, Massachusetts
Ph.D., FACMGChristine Y. Lu
6Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts
Ph.D, M.Sc.Pradeep Natarajan
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
2Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
4Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
7Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts
M.D., M.MSc.Amit V. Khera
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
2Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
M.D., M.S.Krishna G. Aragam
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
2Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
M.D., M.S.Sekar Kathiresan
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
2Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
M.D.Heidi L. Rehm
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
4Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
Ph.D. FACMGMiriam Udler
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
2Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
4Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
8Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts
M.D., Ph.D.
Data Availability
De-identified genomic and phenotype data will be made available upon request through a controlled access database. All variants identified by WGS have been submitted to ClinVar by the Partners Healthcare Personalized Medicine Laboratory for Molecular Medicine.
Posted September 05, 2020.
Prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic test
Deanna G. Brockman, Christina A. Austin-Tse, Renée C. Pelletier, Caroline Harley, Candace Patterson, Holly Head, Courtney Elizabeth Leonard, Kimberly O’Brien, Lisa M. Mahanta, Matthew S. Lebo, Christine Y. Lu, Pradeep Natarajan, Amit V. Khera, Krishna G. Aragam, Sekar Kathiresan, Heidi L. Rehm, Miriam Udler
medRxiv 2020.09.03.20181073; doi: https://doi.org/10.1101/2020.09.03.20181073
Prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic test
Deanna G. Brockman, Christina A. Austin-Tse, Renée C. Pelletier, Caroline Harley, Candace Patterson, Holly Head, Courtney Elizabeth Leonard, Kimberly O’Brien, Lisa M. Mahanta, Matthew S. Lebo, Christine Y. Lu, Pradeep Natarajan, Amit V. Khera, Krishna G. Aragam, Sekar Kathiresan, Heidi L. Rehm, Miriam Udler
medRxiv 2020.09.03.20181073; doi: https://doi.org/10.1101/2020.09.03.20181073
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)